SOURCE: HealthSonix, Inc.

August 15, 2007 08:05 ET

HealthSonix Targets $2.6 Billion Market for Topical Analgesics

IRVINE, CA--(Marketwire - August 15, 2007) - HealthSonix, Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) today announced that it has launched new packaging for its ZingiberRx pain relieving cream. The move follows 3 months of feedback from consumers, particularly the over 50 market, who prefer the easier-to-use tube rather than the jars.

"According to Pain Therapeutics-Drugs, Markets and Companies, October 2005, the worldwide market for pain is estimated at U.S. $50.0 billion for 2005 and is expected to increase to U.S. $75.0 billion by 2010," said Dieter D. Doederlein, Vice President of Corporate Development for HealthSonix. "And according to the Nicholas Hall DB6 database, the global market for OTC sales of topical analgesics is estimated at U.S. $2.6 billion. With a market this size, it was imperative that we address all consumer concerns and this packaging change reflects our commitment and ability to respond quickly to changing trends."

Customers can order ZingiberRx by calling HealthSonix, Inc. on a toll free line at 1-877-622-2121, or by ordering on line at MyArthritisStore.com. HealthSonix is also launching regional sampling programs to increase awareness and encourage trial use of ZingiberRx, particularly among the elderly suffering with arthritis and people active in sports and fitness organizations.

HealthSonix, Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) is a publicly traded medical technology company. The Company's core products are based on proprietary, patent pending medical technologies that use sound pressure waves to stimulate soft tissue, muscles and sensory and mechanoreceptors in the human body to relieve pain. All treatments and products are safe, non-invasive, and have no known side effects.

More information regarding HealthSonix, Inc. and its products and services can be found on the World Wide Web at: www.HealthSonix.com or by calling the company at 1-877-622-2121.

Note: A number of statements contained in this news release are forward-looking statements, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses and other factors not set forth herein. The actual results that the Company may achieve may differ materially from any forward-looking statements due to such risks and uncertainties.

Contact Information